Division of Reproductive Endocrinology, Department of Obstetrics and Gynecology, Madigan Army Medical Center, Tacoma, WA, USA.
Division of Reproductive Endocrinology, Department of Obstetrics and Gynecology, Tripler Army Medical Center, Honolulu, HI, USA.
Hum Reprod Update. 2021 Dec 21;28(1):1-14. doi: 10.1093/humupd/dmab037.
Reported increases in maternal and perinatal morbidity (including macrosomia, large for gestational age (LGA), cesarean section, hemorrhage and hypertensive disorders of pregnancy) following frozen embryo transfer (FET) cycles may be associated with the lack of a corpus luteum seen in programmed FET. Given the growing number of studies comparing outcomes between natural FET and programmed FET cycles, a meta-analysis would prove useful to detect the presence of abnormalities in fetal birth weight in patients undergoing natural and programmed FET cycles.
The aim of this study was to provide a systematic review and meta-analysis of the effects of natural versus programmed methods of endometrial preparation for FET cycles on fetal weight and the risks of LGA and macrosomia.
A literature search using MEDLINE, SCOPUS, EMBASE and clinicaltrials.gov was conducted for published research comparing neonatal outcomes in natural FET and programmed FET cycles. Primary outcomes of interest were fetal weight, macrosomia and LGA. Studies were included if the following criteria were met: study contained cohorts of NFET and programmed FET with outcome data of birth weight, large for gestational data and/or macrosomia. The data are presented as average weight and odds ratio (OR) with 95% confidence interval (CI) with fixed- or random-effects meta-analysis between cohorts of NFET and programmed FET cycles. Bias was assessed using Newcastle-Ottawa quality assessment scale for the 14 included studies. Multiple subgroup analyses were performed to assess for effect of the true natural cycle (defined as no ovulation trigger medication use) and the day of embryo transfer on fetal weight parameters compared with programmed cycle FET.
A total of 879 studies were identified, with 15 meeting inclusion the criteria. The studies varied with respect to country of origin, definition of natural cycle FET and type of progesterone supplementation used. The included studies had similar gestational ages at the time of birth. Programmed FET cycles resulted in a higher fetal weight compared with natural FET cycles (mean difference 47.38 gp = 0.04). Programmed FET cycles were also at higher risk for macrosomia (OR 1.15, 95% CI 1.06-1.26) and LGA (OR 1.10, 95% CI 1.02-1.19) compared with natural FET cycles. Subgroup analyses demonstrated that programmed FET cycles resulted in a higher fetal weight compared with true natural FET (mean difference 62.18 gp = 0.0001) cycles. Cleavage stage embryo transfers had an increased risk of LGA (OR 1.27, 95% CI 1.00-1.62) and an increased risk of macrosomia (OR 1.25, 95% CI 1.08-1.44) in programmed FET cycles compared with natural FET cycles. Blastocyst transfer in programmed FET cycles resulted in no difference in risk of macrosomia but an increased risk of LGA (OR 1.13, 95% CI 1.06-1.21) compared with natural FET cycles.
Programmed endometrial preparation for FET cycles had a significant effect, causing increased fetal birth weight and increased risks of LGA and macrosomia. The numbers of studies in the subgroup analyses were too low to determine reliable results. Further prospective randomized trials are needed to determine whether the changes seen in the observational trials are indeed accurate.
冻融胚胎移植(FET)周期后,母体和围产期发病率(包括巨大儿、胎儿大于胎龄(LGA)、剖宫产、出血和妊娠高血压疾病)的报道增加,这可能与程序性 FET 中黄体缺乏有关。鉴于越来越多的研究比较了自然 FET 和程序性 FET 周期之间的结局,荟萃分析将有助于检测接受自然和程序性 FET 周期的患者胎儿出生体重是否存在异常。
本研究旨在对自然和程序性 FET 周期中子宫内膜准备方法对胎儿体重以及 LGA 和巨大儿风险的影响进行系统评价和荟萃分析。
使用 MEDLINE、SCOPUS、EMBASE 和 clinicaltrials.gov 对比较自然 FET 和程序性 FET 周期新生儿结局的已发表研究进行文献检索。主要结局指标是胎儿体重、巨大儿和 LGA。如果符合以下标准,则纳入研究:研究包含 NFET 和程序性 FET 队列,具有出生体重、胎儿大于胎龄和/或巨大儿的数据。数据以平均体重和优势比(OR)表示,并使用固定或随机效应荟萃分析比较 NFET 和程序性 FET 周期的队列。使用纽卡斯尔-渥太华质量评估量表评估纳入的 14 项研究的偏倚。进行了多项亚组分析,以评估与程序性周期 FET 相比,真正的自然周期(定义为不使用排卵触发药物)和胚胎移植日对胎儿体重参数的影响。
共确定了 879 项研究,其中 15 项符合纳入标准。这些研究在研究来源、自然周期 FET 的定义以及使用的孕激素补充类型方面存在差异。纳入的研究在出生时的胎龄相似。与自然 FET 周期相比,程序性 FET 周期的胎儿体重更高(平均差异 47.38 克,p=0.04)。与自然 FET 周期相比,程序性 FET 周期发生巨大儿的风险更高(OR 1.15,95%CI 1.06-1.26)和 LGA(OR 1.10,95%CI 1.02-1.19)。亚组分析表明,与真正的自然 FET(平均差异 62.18 克,p=0.0001)周期相比,程序性 FET 周期导致胎儿体重更高。与自然 FET 周期相比,胚胎移植处于卵裂期的程序性 FET 周期发生 LGA(OR 1.27,95%CI 1.00-1.62)和巨大儿(OR 1.25,95%CI 1.08-1.44)的风险增加。与自然 FET 周期相比,程序性 FET 周期中的囊胚移植不会增加巨大儿的风险,但会增加 LGA 的风险(OR 1.13,95%CI 1.06-1.21)。
程序性 FET 周期的子宫内膜准备对胎儿出生体重有显著影响,增加了 LGA 和巨大儿的风险。亚组分析中的研究数量太少,无法得出可靠的结果。需要进一步的前瞻性随机试验来确定观察性试验中观察到的变化是否确实准确。